Clinical Trials Directory

Trials / Completed

CompletedNCT02414906

Goal Directed Therapy for Acute Kidney Injury in Critical Ill Patients

Goal Directed Therapy in the Early Phase of Acute Kidney Injury in Critical Ill Patients

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
99 (actual)
Sponsor
Barretos Cancer Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Acute kidney injury (AKI) is a frequent complication in critically ill patients admitted to intensive care unit (ICU) and it is associated with increased morbimortality. There is evidence that perioperative hemodynamic optimization decreases the incidence of AKI in the post operative phase in high-risk patients. We aimed to evaluate if the use of a goal-directed therapy to increase oxygen delivery in the early phase of acute kidney injury can decrease the prevalence of patients with acute renal failure.

Detailed description

Randomized, controlled, multicenter study.The intervention group was monitored with Flo Trac/Vigileo and optimized with fluid challenges, dobutamine and blood transfusion, if necessary, to maintain a IDO² ≥600ml/min/m² during 8h. The control group was treated according to the discretion of the attending physician.

Conditions

Interventions

TypeNameDescription
OTHERGoal-directed therapyGoal-directed therapy with fluids and dobutamine

Timeline

Start date
2010-06-01
Primary completion
2014-02-01
Completion
2014-12-01
First posted
2015-04-13
Last updated
2015-04-13

Source: ClinicalTrials.gov record NCT02414906. Inclusion in this directory is not an endorsement.